Pixium Vision SA - PXH

Pixium Vision SA develops bionic vision restoration systems (VRS) to treat blindness caused by degeneration of photoreceptor cells in the retina. It is developing Intelligent Retinal Implant System VRS, which is in a clinical study that enables blind people to perceive light and shapes, to locate objects, and to negotiate unfamiliar environments; smart bioinspired neuromorphic (event-based) camera; and PRIMA VRS for age-related macular degeneration indication. The company is based in Paris, France.